Roivant Sciences Ltd. (ROIV) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details Roivant Sciences Ltd. (NASDAQ:ROIV) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 29, 2026. The Healthcare…
Read more
